Biotechnology

Techseriesinsight > Blog > News > Biotechnology

November 24, 2025
Business Wire
Biotechnology, News

Gilead Foundation Commits Over $3 Million to Address Food Insecurity

Gilead Foundation today announced that it has committed over $3 million in grants to expand access to food in communities across the United States. Gilead Foundation Healing Hunger awards will enable...

November 21, 2025
Business Wire
Biotechnology, News

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated...

Candela Ushers in a New Era of Aesthetic Innovation

November 19, 2025
Business Wire
Biotechnology, News

Cell and Gene Therapy Business Outlook Service: Market Forecasts, Financing Trends, Deal Tracking, and Technology Insights in a Twice-Monthly Intelligence Format

The “Cell and Gene Therapy Business Outlook” report has been added to ResearchAndMarkets.com’s offering. The Twice-Monthly Publication Cell and Gene Therapy Business Outlook will offer the following: Market Sizing and Forecasting of CAGT...

November 18, 2025
Business Wire
Biotechnology, News

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a...

November 17, 2025
Business Wire
Biotechnology, News

Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (MG) Registry. This nationwide...

November 13, 2025
Business Wire
Biotechnology, News

MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced that Dr. Dirk Van Hyfte, Chief Technology Officer, will participate in a fireside...

November 13, 2025
Business Wire
Biotechnology, News

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Invites investors and the general public to view and listen to a webcast of a discussion with Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London...

November 10, 2025
PRNewswire
Biotechnology, News

Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo

Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics...

November 10, 2025
Business Wire
Biotechnology, News

Virtuoso Surgical Adds Healthcare Innovator Rob Waggener to Board of Directors

A Nashville-based company developing a groundbreaking new class of robotic tools for endoscopic surgery, announced today that nationally recognized healthcare entrepreneur and investor Robert Waggener has joined its Board of...

November 7, 2025
Business Wire
Biotechnology, News

Gilead Provides Update on Phase 3 ASCENT-07 Study

Today announced the Phase 3 ASCENT-07 study investigating Trodelvy® versus chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer patients did not meet the primary endpoint of...